Nurix Therapeutics (NRIX) Cash & Equivalents (2019 - 2026)
Nurix Therapeutics (NRIX) recorded Cash & Equivalents of $720.24 million in fiscal Q3 2026 (quarter ended Aug 31, 2026), up 818.2% from $78.44 million a year earlier and up 964.1% from the prior quarter.
Powered by 
Analysis
Nurix Therapeutics (NRIX) Cash & Equivalents (2019 - 2026) Analysis & Trends
At the end of FY2025 (ended Nov 30, 2025), Nurix Therapeutics reported Cash & Equivalents of $246.96 million, up 124.5% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of 15.7% (FY2020 to FY2025).
- Across earlier fiscal years, Cash & Equivalents came in at $110 million in FY2024 (+101.4%), $54.63 million in FY2023 (-15.3%), $64.47 million in FY2022 (-19.9%) and $80.51 million in FY2021 (-32.5%).
- The fiscal Q3 2026 figure is the highest quarterly Cash & Equivalents in data going back to fiscal Q3 2019.
- On a year-over-year basis, Cash & Equivalents rose in four of the last eight quarters, with growth averaging 127.7%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 818.2% in fiscal Q3 2026, against a decline of 77.9% in fiscal Q2 2022 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $67.69 million (Q2 2026), $71.2 million (Q1 2026) and $246.96 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Nurix Therapeutics | 1.73 Bn | -891.35 Mn | - | 720.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 720.24 Mn |
| May 31, 2026 | 67.69 Mn |
| Feb 28, 2026 | 71.20 Mn |
| Nov 30, 2025 | 246.96 Mn |
| Aug 31, 2025 | 78.44 Mn |
| May 31, 2025 | 84.26 Mn |
| Feb 28, 2025 | 75.92 Mn |
| Nov 30, 2024 | 110.00 Mn |
| Aug 31, 2024 | 99.04 Mn |
| May 31, 2024 | 116.79 Mn |
| Feb 29, 2024 | 49.81 Mn |
| Nov 30, 2023 | 54.63 Mn |
| Aug 31, 2023 | 42.30 Mn |
| May 31, 2023 | 58.96 Mn |
| Feb 28, 2023 | 33.57 Mn |
| Nov 30, 2022 | 64.47 Mn |
| Aug 31, 2022 | 47.56 Mn |
| May 31, 2022 | 41.53 Mn |
| Feb 28, 2022 | 78.78 Mn |
| Nov 30, 2021 | 80.51 Mn |
API Access
Nurix Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();